Summit Therapeu ADR (SMMT)
18.19 -0.01 (-0.05%) 01/16/25 [NASDAQ]
18.11 x 100 18.27 x 800
Realtime by (Cboe BZX)
18.11 x 100 18.27 x 800
Realtime 18.29 +0.10 (+0.55%) 17:19 ET
for Thu, Jan 16th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Sales | 0 | 705 | 1,809 | 860 | 743 |
Gross Profit | N/A | 705 | 1,809 | 860 | 743 |
Operating Expenses | 609,650 | 72,794 | 87,995 | 54,053 | 28,216 |
Operating Income | -609,650 | -72,089 | -86,186 | -53,193 | -27,473 |
Other Income | -5,278 | -6,693 | -2,416 | 283 | -1,618 |
Pre-tax Income | -614,928 | -78,782 | -88,602 | -52,910 | -29,091 |
Income Tax | N/A | N/A | N/A | -213 | 36 |
Net Income Continuous | -614,928 | -78,782 | -88,602 | -52,697 | -29,127 |
Net Income | $-614,928 | $-78,782 | $-88,602 | $-52,697 | $-29,127 |
EPS Basic Total Ops | -0.99 | -0.41 | -0.67 | -0.76 | -0.89 |
EPS Basic Continuous Ops | -0.99 | -0.41 | -0.67 | -0.76 | -0.89 |
EPS Diluted Total Ops | -0.99 | -0.41 | -0.67 | -0.76 | -0.89 |
EPS Diluted Continuous Ops | -0.99 | -0.41 | -0.67 | -0.76 | -0.89 |
EPS Diluted Before Non-Recurring Items | -0.15 | -0.41 | -0.96 | -0.75 | N/A |
EBITDA(a) | $-607,600 | $-69,575 | $-83,731 | $-51,190 | $-25,835 |